may

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…

3 months ago

LINKIN PARK ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI

MILLIONS OF FANS FROM ACROSS THE WORLD TUNED IN TO WATCH THE ICONIC ROCK BAND'S UNMISSABLE PERFORMANCE AHEAD OF THE…

3 months ago

From Declaration to Action: Advancing Global Graft Fight under IAACA Steer

HONG KONG, May 31, 2025 /PRNewswire/ -- In May last year, the International Association of Anti-Corruption Authorities (IAACA), a 180-member-strong…

3 months ago

Fall of Mongolian coalition government could lead to severe economic downturn

Mongolia faces a crunch parliamentary vote on Monday which could lead to fall of coalition governmentNew analysis from Mongolian Economic…

3 months ago

oneworld alliance Strengthens Leadership Team With Three Key Appointments

DELHI, India, May 31, 2025 /PRNewswire/ -- oneworld® alliance today continues to enhance its global capabilities and build a powerful…

3 months ago

University of Phoenix Announces 2025 UOPX Faculty of the Year Award Recipients

Award honors top UOPX faculty nominated by students and faculty colleaguesPHOENIX--(BUSINESS WIRE)--University of Phoenix honored its annual Faculty of the…

3 months ago

Rays Power Infra Ltd Achieves Record Revenue of 1350 Crore in FY25, Up 29% from Previous Year

NEW DELHI, May 30, 2025 /PRNewswire/ -- Rays Power Infra Limited, a prominent business of developing and implementing solar solutions…

3 months ago

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of…

3 months ago

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE

Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…

3 months ago

Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced that he has filed an early warning report…

3 months ago